Health Trials

Siewert Type II Adenocarcinoma of the Esophagogastric Junction

1

Review clinical trials related to Siewert Type II Adenocarcinoma of the Esophagogastric Junction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Study of SHR-1701 Combined With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Evaluating the efficacy and safety of SHR-1701 combined with chemotherapy for the perioperative treatment of locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction.

Participants needed: 38
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Hebei Medical University Fourth HospitalUpdated: May 26, 2026Locations: 1
Eligibility criteria

HB≥90g/L； [+5]

Known signs of active bleeding from the lesion (except for a positive fecal occu... [+12]

Read more